Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 526 of 710

Advanced search

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Elevara Medicines Appoints Biotech Veteran as CEO

markets.businessinsider.comOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Pneumococcal vaccination: expansion of eligibility to people experiencing homelessness

Information on the inclusion of people experiencing homelessness (PEH) as a new clinical risk group...

UK Health Security AgencyOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Laboratory-confirmed Zika virus disease cases: statistics

Epidemiological data on Zika virus disease cases in England, Wales and Northern Ireland.

UK Health Security AgencyOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Laboratory-confirmed typhoid and paratyphoid cases: statistics

Epidemiological data on typhoid and paratyphoid cases in England, Wales and Northern Ireland.

UK Health Security AgencyOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Imported malaria in the UK: statistics

Epidemiological data for imported malaria in the UK.

UK Health Security AgencyOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Laboratory-confirmed dengue cases: statistics

Epidemiological data on laboratory-confirmed dengue cases in England, Wales and Northern Ireland.

UK Health Security AgencyOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Chikungunya: epidemiology in England, Wales and Northern Ireland

Epidemiological data on chikungunya cases in England, Wales and Northern Ireland.

UK Health Security AgencyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

The Economic TimesOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Regulator eases biosimilar approval requirements, waiving some phase 3 trial data

koreabiomed.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Elevara Medicines Appoints Biotech Veteran as CEO

The Manila TimesOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Dizal Pharmaceutical Co Ltd

ReutersOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

HLB's Liver Cancer Drug Fails at FDA's Third Hurdle as China Partner's Plant Again Proves Stumbling Block

finance.biggo.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Stocks in play: Oncolytics Biotech Inc

Barchart.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Middle East Pharmaceutical Grade Polyethylene Glycol - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Millions of unpaid carers to get recognition and earlier support

First ever cross-government action plan to support unpaid carers published.

UK Department of Health and Social CareOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Celltrion Ends Keytruda Biosimilar Phase 3 Trial in Europe Early

Seoul Economic DailyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

Yahoo FinanceOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Astrazeneca strikes exclusive licensing deal with Dizal Pharmaceutical

Sharecast.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma moves urcosimod into global phase 3 trial

Indian Pharma PostOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biovica Receives Ninth Work Order From a Leading Global Pharmaceutical Customer

Yahoo FinanceOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Delivering life: How resilience and innovation define the future of pharmaceutical logistics

Aviation Business NewsOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

ESG: transforming the pharmaceutical supply chain

Manufacturing ChemistOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

ILUVIEN Meets Primary Endpoints in Phase 4 Uveitis Trial at Six Months

The Clinical Trial VanguardOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Excellence in Fluorinated Pharmaceutical Intermediates – Baokai Pharma Sets the Benchmark in High-End Fluorochemicals - ChemNet

ChemNetOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Bavarian Nordic partner applies for approval of chikungunya vaccine in Brazil

medwatch.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

ReutersOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

South Korea eases biosimilar rules to cut trials, time, and costs - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Agenus Secures $340 Million to Fund Phase 3 ROBBIN Trial

Readers.idOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Number of employees of NKGen Biotech Inc. – OTC:NKGNW

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Is your quality system built for 2026’s new regulatory reality?

Pharmaceutical TechnologyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

The FDA’s Psychedelic Guidance Is Really a Study-Design Reckoning

The Clinical Trial VanguardOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biosimilar Development Time and Costs to Be Reduced... Phase 3 Clinical Trial Requirements Eased

아시아경제Original source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

dietary supplement regulation: new global standards

OC AcademyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

[Interview] 'Injectable cell therapy, speroQure, aims to offer a new treatment option for knee osteoarthritis'

koreabiomed.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of CSPC Hunan Jingfeng Pharmaceutical Co Ltd Class A – SZSE:000908

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biogen Shares Rise 5% Ahead of Alzheimer's Drug Trial Data

WhalesbookOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries (TEVA) Could Be 21% Below Fair Value On Vitiligo Trial Progress

Yahoo FinanceOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pune FDA Seizes Unlicensed Ayurvedic Medicines Worth ₹50.36 Lakh

PUNE PULSEOriginal source

🇺🇸Jul 14Regulatoryfda.govTier 1 · Regulatory source

Positive Pressure Breathing Device Correction: Baxter Issues Correction for Volera Positive Pressure Breathing Devices

Volara system patient circuits may leak air and medication from the nebulizer cup during therapy, le...

FDA MedWatchOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Kangmei Pharmaceutical Co., Ltd Class A – SSE:600518

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Zhejiang Starry Pharmaceutical Co., Ltd. Class A – SSE:603520

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

AI MagazineOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Peptron chief Choi buys shares, signals confidence in Lilly tie-up and tech - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Mycenax Biotech Inc. – TPEX:4726

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical venture announces $500M expansion in Northwest Austin

Community ImpactOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biopharma Funds Surge on Deals and Drug Breakthroughs

Institutional InvestorOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Large block sale of Kubota Pharmaceutical Holdings shares (8.19% → 4.32%) by Evo Fund and others.

MoomooOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Crackdown Hits Dairy And Gutkha Supply Chains

WhalesbookOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Ireland seeks balance on biotech incentives and patient interests

euractiv.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Australia's Mesoblast reaches target of 300 trial patients

grafa.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Meet the IAS officer leading Maharashtra's toughest food safety crackdown

India TodayOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk Weaves a Safety Net: Hemophilia Drug Advances as GLP-1 Revenue Faces Halving in 2027

Ad Hoc NewsOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

AstraZeneca enters exclusive global license agreement for novel oral EGFR inhibitor Zegfrovy for lung cancer with Dizal Pharmaceutical

AstraZenecaOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Mesoblast Tests One Injection for Chronic Low Back Pain

Stock TitanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

Yahoo Finance SingaporeOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

After SC, Now Wearables: First FDA Approval for On-Body Injectable Anticancer Drug in the US

아시아경제Original source

🇺🇸Jul 14Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 14Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 14Regulatoryfederalregister.govTier 1 · Regulatory source

Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source

🇺🇸Jul 14Regulatoryfederalregister.govTier 1 · Regulatory source

Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the pote...

Federal RegisterOriginal source